Travelling abroad with cystic fibrosis: Assessment of risks and healthcare requirements

Respir Med. 2017 Apr:125:92-93. doi: 10.1016/j.rmed.2017.01.007. Epub 2017 Jan 24.

Abstract

There is limited information on the risks and healthcare requirements of patients with cystic fibrosis (CF) undertaking travel abroad. Of 100 patients (mean age 24.7 years, mean FEV1 57.3 %predicted) attending a UK adult CF Centre, 96% had travelled abroad but 14% now limited travel on medical advice. They travelled frequently and widely, often undertaking adventurous activities on holidays, but because of the costs involved, 18% travelled without travel insurance and 23% with insurance which did not cover CF. Of those who had ever had an illness abroad 10% had a CF-related illness (7 chest infection, 2 dehydration, 1 pancreatitis) and 12% a non-CF-related illness (4 sunburn, 3 gastroenteritis, 3 ear infection, 1 fall, 1 gastro-oesophageal reflux). There is a wide range of disease severity and assessment of the medical risks and the travel insurance premium to be charged should be based on the individual's health status rather than generically on the basis of a diagnosis of CF.

Keywords: Cystic fibrosis; Healthcare requirements; Risk assessment; Travel; Travel insurance.

MeSH terms

  • Adolescent
  • Adult
  • Cystic Fibrosis / complications
  • Cystic Fibrosis / epidemiology*
  • Cystic Fibrosis / physiopathology
  • Delivery of Health Care / standards*
  • Female
  • Forced Expiratory Volume / physiology
  • Health Education / methods
  • Health Status
  • Humans
  • Infections / epidemiology
  • Male
  • Middle Aged
  • Risk Factors
  • Risk Management / methods*
  • Travel Medicine / economics
  • Travel Medicine / statistics & numerical data*
  • Travel*
  • United Kingdom / epidemiology
  • Young Adult